Platform to Measure How Well Flu and COVID-19 Vaccines Work in Underserved Arizona Communities
Official title: RFA-IP-22-004, Platform to Assess Influenza and COVID-19 Vaccine Effectiveness in Underserved Arizona Populations
Funded at Arizona State University-Tempe Campus · NIH-11381362 · Data updated 2026-11-12
A research effort in Arizona will track how well flu and COVID-19 vaccines protect people in underserved communities, including diverse adults and immunocompromised individuals.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | September 30, 2022 |
| Project end | September 29, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,550,000 |
| NIH project number | 5U01IP001180-05 |
| Project ID | NIH-11381362 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults in underserved Arizona populations who have received influenza and/or COVID-19 vaccines, including immunocompromised individuals.
✕Less likely to help
People who are not part of the study’s participating clinics or who have received vaccines outside the studied settings.
What this research studies
This project uses data from outpatient clinics across a diverse Phoenix-area population to compare the real-world effectiveness of seasonal flu vaccines and COVID-19 vaccines, including boosters, over time. By leveraging ASU resources and local healthcare partners, researchers will analyze vaccine performance in different groups and settings. The study aims to inform vaccination strategies tailored to communities with higher health disparities.
Why it matters
Potential benefit: If successful, the project could improve guidance on who should receive boosters and how vaccines perform in diverse communities.
How similar studies have gone: Prior vaccine effectiveness studies have shown how real-world data can reveal differences by population and variant; this study builds on that approach in a specific, diverse urban setting.
Where this research is happening
-
Arizona State University-Tempe Campus
Scottsdale, United States Active
Researchers
- Principal investigator: Murugan, Vel — Arizona State University-Tempe Campus
- Study coordinator: Murugan, Vel
Related research
Other NIH-funded projects on the same topics.
-
Motivational interviewing to increase COVID-19 and flu vaccination
This project teaches primary care providers conversational skills to help more adults, especially those in vulnerable communities, feel comfortable getting COVID-19 and flu shots.
-
Credible vaccine protection measures for Flu, COVID-19, and other respiratory viruses in Texas ambulatory care
This project looks at how well flu and COVID-19 vaccines protect people from visiting clinics for acute respiratory illnesses in Central Texas.
-
Platform to Measure How Well Seasonal Flu, COVID-19, and Other Respiratory Vaccines Prevent Illness in Real-Life Settings
This grant supports a national effort to track how well respiratory vaccines work in everyday clinics and homes.
-
Vaccine effectiveness in Michigan: how well flu, COVID-19 and other respiratory vaccines work
This project tests how well vaccines against flu, COVID-19, and other respiratory viruses prevent medically attended illness in people visiting outpatient clinics in Southeastern Michigan.
-
How well flu, COVID-19, and other respiratory vaccines protect people in southeastern Michigan
This project checks how well seasonal flu, COVID-19, and other respiratory vaccines protect people who visit clinics for coughs, colds, or breathing problems in southeastern Michigan.
-
How flu, COVID-19, and other respiratory virus vaccines protect against outpatient respiratory illness in Central Texas
This project measures how well flu, COVID-19, and other respiratory virus vaccines prevent people in Central Texas from getting sick enough to seek outpatient medical care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.